EP

Epi Biotech Co., Ltd.

Develops hair loss therapies and provides preclinical CRO services.

446440 | KO

Overview

Corporate Details

ISIN(s):
KR7446440000
LEI:
Country:
South Korea
Address:
인천광역시 연수구 송도과학로 32 엠동 1903호(송도동, 송도테크노파크아이티센터), 인천광역시

Description

Epi Biotech Co., Ltd. is a biopharmaceutical company focused on the research and development of treatments for hair loss. The company utilizes a large genomic database and AI-driven drug discovery platforms to advance its pipeline, which includes cell and antibody therapeutics for hair restoration. In addition to its primary focus, Epi Biotech conducts R&D in skin regeneration. The company also provides specialized preclinical Contract Research Organization (CRO) services, offering expertise in hair loss research and efficacy evaluation.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-07-31 00:00
임시주주총회결과
Korean 8.2 KB
2025-07-31 00:00
주식매수선택권부여에관한신고
Korean 20.6 KB
2025-07-16 00:00
[기재정정]주주총회소집결의
Korean 12.9 KB
2025-07-16 00:00
주주총회소집공고
Korean 71.6 KB
2025-06-24 00:00
주주총회소집결의
Korean 8.1 KB
2025-06-24 00:00
주주명부폐쇄기간또는기준일설정
Korean 4.3 KB
2025-05-12 00:00
주식등의대량보유상황보고서(약식)
Korean 168.9 KB
2025-04-24 00:00
증권발행결과(자율공시)
Korean 5.1 KB
2025-04-16 00:00
주요사항보고서(유상증자결정)
Korean 51.4 KB
2025-03-26 00:00
정기주주총회결과
Korean 17.2 KB
2025-03-26 00:00
주식등의대량보유상황보고서(일반)
Korean 91.4 KB
2025-03-19 00:00
증권발행결과(자율공시)
Korean 5.1 KB
2025-03-19 00:00
증권발행결과(자율공시) (제3자배정 유상증자)
Korean 5.1 KB
2025-03-18 00:00
감사보고서제출
Korean 9.8 KB
2025-03-18 00:00
사업보고서 (2024.12)
Korean 748.3 KB

Automate Your Workflow. Get a real-time feed of all Epi Biotech Co., Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Epi Biotech Co., Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Epi Biotech Co., Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

NANO MRNA Co.,Ltd. Logo
Biotechnology firm creating and out-licensing IP for mRNA-based therapeutics.
Japan
4571
NANOVIRICIDES, INC. Logo
Clinical-stage biopharma developing broad-spectrum, nanomedicine-based antivirals.
United States of America
NNVC
Nautilus Biotechnology, Inc. Logo
Develops a proteome analysis platform to quantify proteins at the single-molecule level.
United States of America
NAUT
NeoImmuneTech, Inc. Logo
A clinical-stage biopharma developing T cell-focused immuno-therapeutics for diseases.
United States of America
950220
Neovacs Logo
Biotech firm developing immunotherapies and investing in BioTech and MedTech.
France
ALNEV
NewAmsterdam Pharma Co N.V. Logo
A clinical-stage biopharma developing therapies for metabolic diseases with unmet needs.
United States of America
NAMS
NextGen Biomed Ltd. Logo
Develops novel therapeutic delivery systems and pain-free auto-injectors.
Israel
NXGN
NEXTURNBIOSCIENCE Co., LTD Logo
Manufacturer of CNC automatic lathes and ultra-precision components for various industries.
South Korea
089140
NFL Biosciences Logo
Biopharmaceutical company developing botanical drug candidates for addiction treatment.
France
ALNFL
NGeneBio Co., Ltd. Logo
Develops NGS-based molecular diagnostic products and software for oncology.
South Korea
354200

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.